Navigation Links
Pfizer Partners with REvolution Computing to Improve Medicine Production Pipeline
Date:4/29/2008

Parallel caret 'R' Software Provides Faster Analysis of Safety

Characteristics of New Drugs

BOSTON, April 29 /PRNewswire/ -- BIO IT World Conference and Exposition -- REvolution Computing, the leading provider of commercial open-source "R" software for computational statistics, today released the results of "A Benchmark Study of Large-Scale Chemical Classification on Quad-Core AMD Systems," a study conducted in partnership with Pfizer on the use of caretNWS, a parallel version of caret implemented using REvolution's Parallel R for high performance classification studies related to safety in drug discovery. The new package, caretNWS, is available for public use and can be accessed at http://www.cran.r-project.org .

The research showed that the parallel caret (caretNWS) software scales well on multiprocessors and speeds the analysis of large data sets, reducing the number of potential candidate molecules for new drugs, making the drug development process more cost efficient and timely.

"Using REvolution Computing's software solutions, we were able to improve our ability to bring new medicines to the market quickly," said Max Kuhn, Associate Director of Non-Clinical Statistics, Pfizer, Inc. "CaretNWS is an asset in the battle against the rising costs associated with new drug development, which is why this is available on a broad, public basis. The ability to conduct large data analysis across multi-core processors represents a significant benefit for drug discovery and development," Kuhn added.

The pharmaceutical industry requires thorough, fast, and inexpensive analysis of large amounts data. However, existing data mining software products are not designed to maximize high performance computers' speed and full capabilities. REvolution Computing answers the problem by deploying open-source analytical language "R" across the multi-processors found in commercial computers thus reducing time, cost and complexity.

For this study, REvolution Computing worked with Pfizer to parallelize its software solution called caret. The parallel caret package, caretNWS, provides parallel processing functionality that allows users the possibility of greatly reducing the computational time to build models without sacrificing model quality.

CaretNWS was used to predict the safety component of compounds, specifically carcinogenic side effects in potential drugs. These models can also eliminate the expensive and time-consuming process of studying a large number of potential compounds in the physical laboratory.

The study concluded that the parallel caret package provides a simple mechanism for practitioners to use the parallelism available in systems based on state-of-the-art multicore processors to accelerate the run time of their production data mining problems.

"We are very pleased with the results achieved by Pfizer with caretNWS. Our success is testimony to the value commercial products based on open-source R bring to the life sciences and other industries where the timely analysis of large sets of data and statistics is a pre-requisite to success," said Richard Schultz, CEO, REvolution Computing.

For a full copy of the "Benchmark Study of Large-Scale Chemical Classification on Quad-Core AMD Systems" please contact REvolution Computing at (203) 777-7442, ext. 262 or info@revolution-computing.com

About REvolution Computing

New Haven, Connecticut-based REvolution Computing is the leading commercial provider of software and support for the statistical computing language known as "R." Our products enable statisticians, scientists and others to derive meaning from large sets of mission-critical data in record time, and to create predictive models that help to answer their most difficult questions. REvolution Computing works closely with the R community to incorporate the latest developments in open source R, and with our clients to support their efforts to produce groundbreaking innovations in life sciences, financial services, defense technology and other industries where high-level analytics are crucial to success. At Revolution Computing, "we do the math."


'/>"/>
SOURCE REvolution Computing
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. AUDIO from Medialink and Pfizer: Number of Uninsured Americans Grows to 47 Million
2. AUDIO from Medialink and Pfizer: Prescription for Safer Drugs Discussed in Washington
3. AUDIO from Medialink and Pfizer: A New Prescription for Safer Drugs
4. Former Pfizer Patent Attorneys Join Brinks Hofer Gilson & Lione
5. Pfizer Closes La Jolla Campus Due to Continuing Fire Emergency
6. AUDIO From Medialink and Pfizer: Help Is Available for Caregivers and for Loved Ones
7. A Major Gift of Art and History: U-M Receives 45 Significant Medical Paintings From Pfizer
8. Novo Nordisk Settles With Pfizer On Patent Infringement Suit
9. AUDIO from Medialink and Pfizer: Helping Uninsured Americans Achieve New Years Resolutions to be Healthier
10. IPM Reaches Landmark Agreement with Pfizer to Develop FDA-Approved Antiretroviral Drug as Vaginal Microbicide
11. AUDIO from Medialink and Pfizer: February is National Heart Month
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/28/2017)... ... 28, 2017 , ... Accreditation Commission for Health Care (ACHC) ... America (HCAOA). This agreement allows HCAOA members to receive special pricing on ACHC’s ... Accreditation University (AU) educational resources that help prepare HCAOA members for ACHC Accreditation. ...
(Date:4/28/2017)... (PRWEB) , ... April 28, 2017 , ... Getting enough sleep affects much more than ... (NSF), going just 19 hours without sleep can compromise motor reaction time, which can increase ... and Amica Insurance is sharing the following tips from the NSF to help you sleep ...
(Date:4/28/2017)... ... April 28, 2017 , ... Datta Endoscopic Back Surgery ... the revolutionary endoscopic practice under Dr. Datta. Patel is a Board Certified Anesthesiologist, ... patented, revolutionary eDiscSculpt Technique created and used by Datta Endoscopic is unlike traditional ...
(Date:4/28/2017)... (PRWEB) , ... April 28, 2017 , ... People are ... older people. “Wearing a hearing aid doesn’t have the stigma it had when great-grandpa ... Hearing Associates of Greater Boston, in a NALA North American Speaker Series ...
(Date:4/28/2017)... ... April 28, 2017 , ... Intellitec Solutions ... Grove Foundation implement a Microsoft Dynamics GP solution that integrates to their PointClickCare ... that specializes in long-term care, Brooke Grove now has the capability to achieve ...
Breaking Medicine News(10 mins):
(Date:4/19/2017)... Calif. , April 19, 2017  IRIDEX Corporation ... will release financial results for the first quarter 2017 ... 2017.  The Company,s management team will host a corresponding ... p.m. ET. Investors interested in listening to ... 707-0665 for domestic callers or (703) 326-3030 for international ...
(Date:4/19/2017)... NEW YORK , April 19, 2017 /PRNewswire/ ... This report on the prostate cancer ... of the global market. Increasing prevalence of prostate ... as innovation in the development of new drugs ... hormone-refractory prostate cancer drug due to lesser side ...
(Date:4/19/2017)... India , April 19, 2017 ... and Application, Forecast to 2022 report has covered and analysed ... statistics and information on market size, shares and growth factors. ... major drivers, challenges and opportunities in the global market. ... Browse 152 Tables and Figures, ...
Breaking Medicine Technology: